New Cell Therapy for Multiple Sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests a new cell therapy called STAR-T to see if it is safe and helps people with multiple sclerosis (MS). The therapy uses immune cells that are grown in the lab and put back into your body to potentially slow or stop MS progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old
- You have been diagnosed with MS (any type: relapsing-remitting, primary progressive, or secondary progressive) with disability level between 2 and 7 on the EDSS scale
- Your MS must be active or hard to control despite current treatments, or you need to show recent disease activity on brain imaging
- Your blood counts, liver, kidney, and heart function must be healthy enough for the treatment
- You must use reliable birth control for 12 months after treatment if you can have children
- You cannot have had certain recent infections, cancer, hepatitis, HIV, tuberculosis, or severe drug allergies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gene therapy called GT802 for people with relapsing-remitting MS that hasn't responded to usual treatments. The goal is to see if it can control the disease safely and effectively.
This trial tests a new cell therapy called SYS6020 for people with multiple sclerosis that has not improved with standard treatments. The goal is to see if it can slow or stop the disease and improve symptoms.
This trial tests whether an injection of special immune cells called STAR-T cells can help people with generalized myasthenia gravis. It is for those whose symptoms are moderate to severe and haven't improved enough after at least two standard treatments.
This trial tests a new cell therapy called S103 for people with MS that isn't responding well to standard treatments. The therapy involves modifying immune cells in the lab and putting them back into your body to help control the disease.
This trial tests if using your own stem cells can stop multiple sclerosis that keeps getting worse despite treatment. You would first receive a medication to reset your immune system, then get your stem cells back to help rebuild it.
This trial tests a new treatment called MB-CART2019.1, which uses your own immune cells to fight multiple sclerosis. It is for people with progressive or worsening MS who have not responded well to other treatments.
Hear when a new Multiple Sclerosis (MS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.